Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC

Novel Cell Sieve Reduces Risk of Contamination During Filtration of Cell Suspensions and Primary Cell Isolates

By BiotechDaily International staff writers
Posted on 15 Aug 2013
Image: EASYstrainer cell sieve for filtration of cell suspensions and primary cell isolates (Photo courtesy of Greiner Bio-One).
Image: EASYstrainer cell sieve for filtration of cell suspensions and primary cell isolates (Photo courtesy of Greiner Bio-One).
A novel sterile, single-use cell sieve is ideal for preparing single cells for flow cytometry and to separate individual cells after organ digestion as part of the primary cell extraction process.

Greiner Bio-One (Kremsmuenster, Austria), a company that has focused on the development, production, and distribution of plastic laboratory products, has introduced EASYstrainer, a cell sieve for the filtration of cell suspensions.

To prevent sterile filter material from becoming contaminated through accidental contact EASYstrainer was designed with a circumferential mantle surface and handle fitted directly on the sieve. The unit is sealed in blister packaging that ensures reliable, aseptic removal of sieves from the pack.

The EASYstrainer features a venting slot between the collection tube and the attached cell sieve. Air in the tube escapes through this slot during the rapid filtration step, and overflow is avoided. This special property prevents the accumulation of filtration liquid between the sieve and tube and thus the associated risk of contamination.

EASYstrainer is suitable for all standard 50 ml tubes and is available in mesh widths of 40, 70, and 100 microliters.

Related Links:
Greiner Bio-One


Channels

Genomics/Proteomics

view channel
Image: Researchers have generated disease-free stem cells from patients with mitochondrial disease that can be converted into any cell type including neuronal progenitors (left) or heart cells (right). These could potentially be used for future transplantation into patients (Photo courtesy of Salk Institute of Biological Studies).

Methods Developed to Generate Normal Stem Cells from Patients with Mitochondrial Defects

A recent paper described two methods for converting cells from patients with mitochondrial defects into normal pluripotent stem cells that could be induced to differentiate into several different types of tissues.... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Lab Technologies

view channel
Image: The Leica DM2500 LED Microscope for clinical laboratories and research applications (Photo courtesy of Leica Microsystems).

New LED Microscope Completes Line of Clinical and Research Tools

A popular microscope used for both clinical and research applications is now available with LED illumination. The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.